Maxcyte Inc
MXCT
$1.4+0.04 (+2.94%)
Aug 18, 2025, 4:00 PM
Financials
| 52Week High | 5.20 | 52Week Low | 1.26 |
| Beta | 1.31 | Current Ratio Annual | 10.88 |
| Current Ratio Quarterly | 12.39 | Gross Margin TTM | 79.79 |
| Market Cap | 146.58M | Net Profit Margin TTM | -125.22 |
| Operating Margin TTM | -149.57 | Price To Book | 0.77 |
| Price To Sales TTM | 4.10 | Quick Ratio Annual | 10.09 |
| Quick Ratio Quarterly | 11.45 | Return On Assets TTM | -19.10 |
| Return On Equity TTM | -22.12 | Return On Investment TTM | -22.12 |
| Revenue Growth3Y | 4.46 | Revenue Growth5Y | 12.31 |
| Revenue Growth Quarterly Yoy | -18.43 | Revenue Growth TTMYoy | -21.31 |
| Revenue Per Share TTM | 0.34 |
13F Aggregates
| Quarter | Funds | Added | Exited | Increased | Decreased | Unchanged | Shares | Value |
|---|---|---|---|---|---|---|---|---|
| Dec 31, 2024 | 120 | 0 | 0 | 4 | 6 | 0 | 72.62M | $300.23M |
| Mar 31, 2025 | 114(-5%) | 10(+%) | 15(+%) | 39(+875%) | 43(+617%) | 19(+%) | 71.89M(-1%) | $195.42M(-35%) |
| Jun 30, 2025 | 116(+2%) | 11(+10%) | 15 | 43(+10%) | 35(-19%) | 18(-5%) | 64.25M(-11%) | $138.59M(-29%) |